In 2024, the Sanara R&D team submitted 11 provisional patent applications covering innovations in proprietary antimicrobial technologies and hydrolyzed collagen, including novel formulations, ...

Here we have picked four large-cap MedTech stocks, namely McKesson Corporation MCK, ResMed Inc. RMD, Penumbra ... from a higher volume of specialty products, including an increase in volume ...

Johnson & Johnson (NYSE: JNJ) shares dipped slightly before hours today on fourth-quarter results that topped the consensus ...

Sanara MedTech Inc. (NASDAQ:SMTI) recently reported in a Form 8-K filing with the Securities and Exchange Commission dated January 15, 2025, the appointment of Elizabeth B. Taylor as the Chief ...